Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Blue Jet Healthcare shares rally 9% after Rs 800 crore QIP allotment
Blue Jet Healthcare shares rose sharply on Friday after the company completed its Rs 800 crore QIP, attracting marquee institutional investors, including multiple ICICI Prudential Mutual Fund schemes. The fund raise is expected to strengthen the company's balance sheet, support expansion plans, and boost long-term growth prospects while broadening its institutional shareholder base.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Barometers extend winning streak for 3rd session; Nifty settles above 24,250 mark
The Nifty settled above the 24,250 mark. Realty, IT and pharma shares advanced, while PSU bank, media and auto shares declined.
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Ends 261 Points Higher | Nifty Above 24,250 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
10 smallcap stocks soar up to 212% this year, 3 turn multibaggers. Do you own any?
India's smallcap stocks have outperformed the Nifty 50 in 2026, with HFCL, Aditya Infotech and Acutaas Chemicals leading the top 10 performers, delivering exceptional year-to-date returns.
Market wrap: Sensex falls 250 points, Nifty closes below 23,900 on monthly expiry day
Indian equities ended lower for the second straight session as benchmarks slipped on expiry-day volatility, though broader markets advanced. IT stocks led declines amid rate worries, while auto and consumption names gained. Analysts expect sectoral rotation ahead of earnings, with banking, healthcare and power seen as resilient drivers of performance.

Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Stock Market LIVE: Sensex up 300 pts, Nifty above 23,850; IT, pharma & healthcare stocks lead
Sensex Today | Stock Market LIVE Updates Wednesday: In the broader markets, the Nifty MidCap and the Nifty SmallCap were trading 0.04 per cent and 0.12 per cent lower, respectively
Nifty, Bank Nifty outlook & stock recommendations by Motilal Oswal
Chandan Taparia of Motilal Oswal Financial Services expects Nifty and Bank Nifty to trade with a weak bias as long as they remain below 23,850 and 57,250, respectively.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.